Logo image of HOLX

HOLOGIC INC (HOLX) Stock Fundamental Analysis

NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD

63.93  +0.69 (+1.09%)

After market: 63.93 0 (0%)

Fundamental Rating

6

Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 190 industry peers in the Health Care Equipment & Supplies industry. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HOLX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in each of the past 5 years.
In the past 5 years HOLX always reported a positive cash flow from operatings.
HOLX Yearly Net Income VS EBIT VS OCF VS FCFHOLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

HOLX has a Return On Assets of 8.52%. This is amongst the best in the industry. HOLX outperforms 90.43% of its industry peers.
With an excellent Return On Equity value of 15.59%, HOLX belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 10.23%, HOLX belongs to the top of the industry, outperforming 90.43% of the companies in the same industry.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 8.14%.
Industry RankSector Rank
ROA 8.52%
ROE 15.59%
ROIC 10.23%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
HOLX Yearly ROA, ROE, ROICHOLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

The Profit Margin of HOLX (18.42%) is better than 92.55% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.66%, HOLX belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin (56.45%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HOLX has grown nicely.
Industry RankSector Rank
OM 24.66%
PM (TTM) 18.42%
GM 56.45%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
HOLX Yearly Profit, Operating, Gross MarginsHOLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HOLX is creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
Compared to 1 year ago, HOLX has an improved debt to assets ratio.
HOLX Yearly Shares OutstandingHOLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
HOLX Yearly Total Debt VS Total AssetsHOLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.85 indicates that HOLX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.85, HOLX is doing good in the industry, outperforming 71.81% of the companies in the same industry.
HOLX has a debt to FCF ratio of 2.30. This is a good value and a sign of high solvency as HOLX would need 2.30 years to pay back of all of its debts.
The Debt to FCF ratio of HOLX (2.30) is better than 87.77% of its industry peers.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a worse Debt to Equity ratio (0.52) than 63.83% of its industry peers.
Even though the debt/equity ratio score it not favorable for HOLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.3
Altman-Z 3.85
ROIC/WACC1.19
WACC8.6%
HOLX Yearly LT Debt VS Equity VS FCFHOLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

HOLX has a Current Ratio of 3.49. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.49, HOLX is in the better half of the industry, outperforming 62.23% of the companies in the same industry.
A Quick Ratio of 2.78 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.78, HOLX is doing good in the industry, outperforming 60.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 2.78
HOLX Yearly Current Assets VS Current LiabilitesHOLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.99%.
The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
Looking at the last year, HOLX shows a small growth in Revenue. The Revenue has grown by 1.76% in the last year.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)6.99%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%5.1%
Revenue 1Y (TTM)1.76%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%0.86%

3.2 Future

Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 5.85% on average per year.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.49% on average per year.
EPS Next Y6.65%
EPS Next 2Y7.77%
EPS Next 3Y8.33%
EPS Next 5Y5.85%
Revenue Next Year3.54%
Revenue Next 2Y4.62%
Revenue Next 3Y5.07%
Revenue Next 5Y4.49%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HOLX Yearly Revenue VS EstimatesHOLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
HOLX Yearly EPS VS EstimatesHOLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.48, HOLX is valued correctly.
89.89% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
HOLX is valuated rather cheaply when we compare the Price/Earnings ratio to 30.43, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.49, which indicates a correct valuation of HOLX.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaper than 92.02% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, HOLX is valued a bit cheaper.
Industry RankSector Rank
PE 15.48
Fwd PE 13.49
HOLX Price Earnings VS Forward Price EarningsHOLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

90.43% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
94.15% of the companies in the same industry are more expensive than HOLX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.98
EV/EBITDA 11.41
HOLX Per share dataHOLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
HOLX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.33
PEG (5Y)1.43
EPS Next 2Y7.77%
EPS Next 3Y8.33%

0

5. Dividend

5.1 Amount

HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HOLOGIC INC

NASDAQ:HOLX (2/18/2025, 8:00:01 PM)

After market: 63.93 0 (0%)

63.93

+0.69 (+1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners100.25%
Inst Owner Change-0.59%
Ins Owners0.71%
Ins Owner Change3.23%
Market Cap14.35B
Analysts73.57
Price Target87.51 (36.88%)
Short Float %2.66%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.44%
Min EPS beat(2)-2.26%
Max EPS beat(2)-0.62%
EPS beat(4)2
Avg EPS beat(4)0.68%
Min EPS beat(4)-2.26%
Max EPS beat(4)3.3%
EPS beat(8)6
Avg EPS beat(8)3.47%
EPS beat(12)10
Avg EPS beat(12)10.84%
EPS beat(16)13
Avg EPS beat(16)16.62%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-0.84%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.41%
Revenue beat(8)3
Avg Revenue beat(8)0.03%
Revenue beat(12)7
Avg Revenue beat(12)2.57%
Revenue beat(16)10
Avg Revenue beat(16)5.29%
PT rev (1m)-1.15%
PT rev (3m)-3.02%
EPS NQ rev (1m)-4.65%
EPS NQ rev (3m)-7.87%
EPS NY rev (1m)0.16%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)-3.86%
Revenue NQ rev (3m)-5.46%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 15.48
Fwd PE 13.49
P/S 3.55
P/FCF 12.98
P/OCF 11.44
P/B 3.01
P/tB 25.75
EV/EBITDA 11.41
EPS(TTM)4.13
EY6.46%
EPS(NY)4.74
Fwd EY7.41%
FCF(TTM)4.93
FCFY7.7%
OCF(TTM)5.59
OCFY8.75%
SpS18
BVpS21.27
TBVpS2.48
PEG (NY)2.33
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 8.52%
ROE 15.59%
ROCE 12.89%
ROIC 10.23%
ROICexc 13.74%
ROICexgc 51.4%
OM 24.66%
PM (TTM) 18.42%
GM 56.45%
FCFM 27.37%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.3
Debt/EBITDA 1.93
Cap/Depr 50.64%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 97.21%
Profit Quality 148.56%
Current Ratio 3.49
Quick Ratio 2.78
Altman-Z 3.85
F-Score7
WACC8.6%
ROIC/WACC1.19
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)6.99%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%5.1%
EPS Next Y6.65%
EPS Next 2Y7.77%
EPS Next 3Y8.33%
EPS Next 5Y5.85%
Revenue 1Y (TTM)1.76%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%0.86%
Revenue Next Year3.54%
Revenue Next 2Y4.62%
Revenue Next 3Y5.07%
Revenue Next 5Y4.49%
EBIT growth 1Y10.13%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year17.91%
EBIT Next 3Y10.15%
EBIT Next 5Y9.03%
FCF growth 1Y-34.04%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y-30.88%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%